JP2021520792A5 - - Google Patents

Info

Publication number
JP2021520792A5
JP2021520792A5 JP2020555110A JP2020555110A JP2021520792A5 JP 2021520792 A5 JP2021520792 A5 JP 2021520792A5 JP 2020555110 A JP2020555110 A JP 2020555110A JP 2020555110 A JP2020555110 A JP 2020555110A JP 2021520792 A5 JP2021520792 A5 JP 2021520792A5
Authority
JP
Japan
Prior art keywords
cells
manipulated
nucleic acid
cytolytic immune
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020555110A
Other languages
English (en)
Japanese (ja)
Other versions
JP7527965B2 (ja
JP2021520792A (ja
Filing date
Publication date
Priority claimed from GBGB1805918.8A external-priority patent/GB201805918D0/en
Application filed filed Critical
Publication of JP2021520792A publication Critical patent/JP2021520792A/ja
Publication of JP2021520792A5 publication Critical patent/JP2021520792A5/ja
Priority to JP2024016241A priority Critical patent/JP2024036532A/ja
Application granted granted Critical
Publication of JP7527965B2 publication Critical patent/JP7527965B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020555110A 2018-04-10 2019-04-09 操作された細胞溶解性免疫細胞 Active JP7527965B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024016241A JP2024036532A (ja) 2018-04-10 2024-02-06 操作された細胞溶解性免疫細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1805918.8A GB201805918D0 (en) 2018-04-10 2018-04-10 Cell
GB1805918.8 2018-04-10
PCT/GB2019/051031 WO2019197819A1 (en) 2018-04-10 2019-04-09 Engineered cytolytic immunecell

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024016241A Division JP2024036532A (ja) 2018-04-10 2024-02-06 操作された細胞溶解性免疫細胞

Publications (3)

Publication Number Publication Date
JP2021520792A JP2021520792A (ja) 2021-08-26
JP2021520792A5 true JP2021520792A5 (enExample) 2022-02-21
JP7527965B2 JP7527965B2 (ja) 2024-08-05

Family

ID=62202947

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020555110A Active JP7527965B2 (ja) 2018-04-10 2019-04-09 操作された細胞溶解性免疫細胞
JP2024016241A Pending JP2024036532A (ja) 2018-04-10 2024-02-06 操作された細胞溶解性免疫細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024016241A Pending JP2024036532A (ja) 2018-04-10 2024-02-06 操作された細胞溶解性免疫細胞

Country Status (8)

Country Link
US (2) US20210032655A1 (enExample)
EP (1) EP3775895A1 (enExample)
JP (2) JP7527965B2 (enExample)
CN (2) CN117683082A (enExample)
AU (1) AU2019253507A1 (enExample)
CA (1) CA3096240A1 (enExample)
GB (1) GB201805918D0 (enExample)
WO (1) WO2019197819A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201914611D0 (en) * 2019-10-09 2019-11-20 Autolus Ltd Engineered immune cell
WO2024238824A1 (en) * 2023-05-17 2024-11-21 Legend Biotech Usa Inc. Fusion proteins and methods of use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1144655A2 (en) * 1998-10-19 2001-10-17 Ariad Gene Therapeutics, Inc. Regulated expression using conditional er retention domains
JP2002541845A (ja) 1999-04-16 2002-12-10 セルテック セラピューティックス リミテッド 合成膜貫通成分
WO2015142661A1 (en) * 2014-03-15 2015-09-24 Novartis Ag Regulatable chimeric antigen receptor
CN106661245B (zh) 2014-07-28 2020-08-21 住友化学株式会社 膜的制造方法及涂布液的保管方法
GB201415347D0 (en) * 2014-08-29 2014-10-15 Ucl Business Plc Signalling system
GB201503133D0 (en) 2015-02-24 2015-04-08 Ucl Business Plc And Syncona Partners Llp Chimeric protein
GB201507108D0 (en) * 2015-04-27 2015-06-10 Ucl Business Plc Nucleic acid construct
GB201507115D0 (en) * 2015-04-27 2015-06-10 Ucl Business Plc Nucleic Acid Construct
GB201507119D0 (en) * 2015-04-27 2015-06-10 Ucl Business Plc Nucleic Acid Construct
GB201507104D0 (en) * 2015-04-27 2015-06-10 Ucl Business Plc Nucleic acid construct
GB201507111D0 (en) * 2015-04-27 2015-06-10 Ucl Business Plc Nucleic acid construct
GB201602563D0 (en) 2016-02-12 2016-03-30 Autolus Ltd Signalling system
CA2937157A1 (en) * 2016-07-25 2018-01-25 Ucl Business Ltd Protein-based t-cell receptor knockdown
WO2018211244A1 (en) 2017-05-15 2018-11-22 Autolus Limited A cell comprising a chimeric antigen receptor (car)
GB201707779D0 (en) 2017-05-15 2017-06-28 Autolus Ltd Cell
GB201714718D0 (en) * 2017-09-13 2017-10-25 Autolus Ltd Cell
GB201914611D0 (en) 2019-10-09 2019-11-20 Autolus Ltd Engineered immune cell

Similar Documents

Publication Publication Date Title
JP7149273B2 (ja) Ｃａｒおよび転写因子を発現する細胞、ならびにその使用
Rescigno et al. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
JP5651583B2 (ja) 自己免疫疾患の治療および／または予防のための薬剤、ならびに制御性ｔ細胞形成のための薬剤
AU2016318230B2 (en) Chimeric antigen receptors and uses thereof
JP2021518161A5 (enExample)
JP2021518160A5 (enExample)
CN109121413A (zh) 使用靶向核酸纳米载体编程治疗性细胞的组合物和方法
CN113785048B (zh) 用于扩增和分化在过继转移疗法中的t淋巴细胞和nk细胞的方法
CN113195527A (zh) Tcr和肽
CN118234490A (zh) 用于细胞特异性免疫调节的载脂蛋白融合蛋白
TW202241937A (zh) 用於追踪基因工程細胞的肽標記
CN113660942A (zh) 嵌合细胞因子受体
JP2026082892A (ja) Ｃｘｃｒ４及びｉｌ－１０を共発現する間葉系幹細胞並びにその使用
JP2025512886A (ja) キメラサイトカイン受容体
CN110114466A (zh) 转录系统
Jung et al. Stimulatory effect of HGF‐overexpressing adipose tissue‐derived mesenchymal stem cells on thymus regeneration in a rat thymus involution model
CN108603172A (zh) 治疗性t细胞
JP2024036532A (ja) 操作された細胞溶解性免疫細胞
JP2023515806A5 (enExample)
EP4289859A1 (en) Fusion protein for maintenance of regulatory t-cells
EP3864034A1 (en) Cell
JP2019532036A (ja) メラノーマの処置のための方法および組成物
US20250353889A1 (en) Fusion protein for maintenance of regulatory t-cells
KR20230019117A (ko) 개선된 백신 제제
CN118176206A (zh) 靶向细胞疗法